Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study

Open Access

Peer-reviewed

Research Article

James C. Scott,

Affiliations Colby College, Department of Mathematics and Statistics, Waterville, Maine, United States of America, Francis I. Proctor Foundation, San Francisco, California, United States of America
⨯
Neha Shah ,

* E-mail: nshah6@cdc.gov

Affiliations California Department of Health Tuberculosis Control Branch, Richmond, California, United States of America, Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, Georgia, United States of America
⨯
Travis Porco,

Affiliations Francis I. Proctor Foundation, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America
⨯
Jennifer Flood

Affiliation California Department of Health Tuberculosis Control Branch, Richmond, California, United States of America
⨯

Reader Comments (0)

Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
Drug prices
Is the Subject Area "Drug prices" applicable to this article?

Thanks for your feedback.
Shortages
Is the Subject Area "Shortages" applicable to this article?

Thanks for your feedback.
Cohort studies
Is the Subject Area "Cohort studies" applicable to this article?

Thanks for your feedback.
Liver transplantation
Is the Subject Area "Liver transplantation" applicable to this article?

Thanks for your feedback.